CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 56 filers reported holding CARDIFF ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $4,959,349 | +364.1% | 928,717 | +28.6% | 0.04% | +366.7% |
| Q4 2023 | $1,068,708 | +6.5% | 722,100 | 0.0% | 0.01% | +50.0% |
| Q3 2023 | $1,003,719 | -5.4% | 722,100 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $1,061,487 | -10.9% | 722,100 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $1,191,465 | +17.9% | 722,100 | 0.0% | 0.01% | +60.0% |
| Q4 2022 | $1,010,940 | -9.1% | 722,100 | 0.0% | 0.01% | -28.6% |
| Q3 2022 | $1,112,000 | -30.0% | 722,100 | 0.0% | 0.01% | -72.0% |
| Q2 2022 | $1,589,000 | – | 722,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,845,164 | $26,183,000 | 24.69% |
| Corriente Advisors, LLC | 910,000 | $12,913,000 | 6.55% |
| Opaleye Management Inc. | 1,731,600 | $24,571,000 | 4.80% |
| VR Adviser, LLC | 1,271,985 | $18,049,000 | 3.53% |
| Soleus Capital Management, L.P. | 281,819 | $3,999,000 | 2.12% |
| Blue Rock Advisors, LLC | 106,481 | $1,511,000 | 1.30% |
| ACUTA CAPITAL PARTNERS, LLC | 305,900 | $4,341,000 | 1.18% |
| EAM Investors, LLC | 332,900 | $4,724,000 | 1.12% |
| RA Capital Management | 3,290,000 | $46,685,000 | 0.85% |
| EAM Global Investors LLC | 140,231 | $1,990,000 | 0.73% |